INO
INO
NASDAQ · Biotechnology

Inovio Pharmaceuticals Inc

$1.43
-0.03 (-2.05%)
Analyst Consensus
Buy
7
Analysts
Moderate
Coverage
Buy 5 71%
Hold 2 29%
Sell 0 0%
Price Target
Analyst Price Target +1,271.3% upside
Low Target $14.26
Average Target $19.61
High Target $29.32
Current Price $1.43
Current
$1.43
Target
$19.61
$14.26 $19.61 avg $29.32
Scenario Analysis
Bear Case
$14.26
897.2%
Low target
Base Case
$19.61
+1,271.3%
Avg target
Bull Case
$29.32
+1,950.3%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$2.72
-47.4% from high
52-Week Low
$0.56
+153.9% from low
Target vs 52W High
$19.61
+621.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.2%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +114.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -17.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
MRNA
Moderna Inc
Hold 31 32% $149.45 -30.6%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -50.5%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -31.6%